Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database. [PDF]
Qian J, Gong Y, Zhang C, Zhou L.
europepmc +1 more source
The effects of dutasteride and tamsulosin, alone or in association, in the kidney morphology: experimental study in rats. [PDF]
Silva MHAD +4 more
europepmc +1 more source
Uroselective Alpha-1A Blockade Versus Surgical De-Obstruction: Differential Associations with Heart Rate Variability Restoration and Symptom Relief in Benign Prostatic Hyperplasia with Bladder Outlet Obstruction. [PDF]
Chen KY +8 more
europepmc +1 more source
Optimizing [<sup>99m</sup>Tc]Tc-Tamsulosin for Enhanced Tumor Detection: A Comprehensive Approach from Preparation to In Vivo Evaluation. [PDF]
Sanad MH, Challan SB, Massoud A.
europepmc +1 more source
Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men: A Randomized Clinical Trial.
Bauer SR +11 more
europepmc +1 more source
A QbD-based method for the simultaneous determination of tadalafil, terazosin, and tamsulosin using organic-solvent free mixed-micellar HPLC: a sustainable green approach. [PDF]
Alrashdi YBA +6 more
europepmc +1 more source
Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. [PDF]
Schwartzmann I +9 more
europepmc +1 more source
The efficacy of tamsulosin 0.4 mg when tamsulosin 0.2 mg is insufficient for benign prostatic hyperplasia in Korean patients. [PDF]
Chung Y, Jeong SJ, Song SH, Hong SK.
europepmc +1 more source
A fixed dose combination of tamsulosin and tadalafil in men with benign prostatic hyperplasia and erectile dysfunction: a prospective, multicenter, phase IV study. [PDF]
Gupta C +13 more
europepmc +1 more source
Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially? [PDF]
Tian S +6 more
europepmc +1 more source

